J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...
FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...
Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...
Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...
The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.
The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...
It is a fictional representation created for illustrative purposes only. The U.S. FDA approved Johnson & Johnson's Varipulse, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback